Project Grant HT94252510869
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,486,400 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports a 4-year research project titled "STRUCTURAL DIAGNOSIS OF TAUOPATHIES" with a period of performance from June 15, 2024 to June 14, 2028. Through this grant, UT Southwestern will conduct innovative biomedical research on tauopathies, a class of...
The University of Texas Southwestern Medical Center was awarded a $1,639,837 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The 4-year grant, awarded on June 15, 2024, supports a research project titled "STRUCTURAL DIAGNOSIS OF TAUOPATHIES" focused on advancing the diagnosis and treatment of neurodegenerative tauopathies. As a leading academic medical center, UT Southwestern will leverage its expertise in biomedical...
This federal Project Grant award in the amount of $617,537 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 1, 2024 to August 31, 2027, supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to examine heterogeneity in response to disease-modifying therapy for multiple sclerosis. As a prominent academic medical center, UT...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
The Defense Health Agency awarded a $725,000 project grant to The University of Texas Southwestern Medical Center in Dallas, Texas, for research under the Military Medical Research and Development program. The three-year award beginning June 15, 2023, will support research into glutamine-targeted therapies to prevent traumatic heterotopic ossification. As the parent organization, the University of Texas System will provide research support services through this subaward. The Military Medical...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $769,578 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENHANCING BIOENERGETICS AS A STRATEGY TO IMPROVE OUTCOME AFTER MILD TRAUMATIC BRAIN INJURY". The award, which runs from May 1, 2024 to April 30, 2027, will support UTHealth's efforts to advance scientific knowledge and develop innovative treatments for...
This Project Grant award for $737,998.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program, will fund research by The University of Texas Southwestern Medical Center to target MNK signaling to prevent and reverse chronic pain caused by complex traumatic injury. The research aims to develop innovative therapeutic approaches to address this significant medical challenge affecting military personnel. As a prominent academic...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $713,689 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, effective September 1, 2023, will support UT Southwestern's research to leverage biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. The grant provides funding for basic...
This federal Project Grant award, valued at $363,160.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant funds the University of Texas Southwestern Medical Center, also known as Southwestern Medical School, to conduct research on the development of bioresorbable heart valves. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by...